Navigation Links
New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
Date:1/30/2009

oring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that the positive results and clinical outcomes achieved in this study will be repeated in other studies, and risks related to our assumption that Masimo pulse oximetry technologies and devices will deliver a sufficient level of sensitivity for improved CHD detection over alternative methods of newborn screening to allow for rapid adoption of the technology, as well as other factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2008, filed with the Securities and Exchange Commission ("SEC") on October 29, 2008, which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-
'/>"/>

SOURCE Masimo
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study
2. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
3. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
4. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
5. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
6. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
7. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
8. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
9. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
10. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
11. Study Shows Machine Perfusion Significantly Improves Transplant Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 Cloud Pharmaceuticals, ... design and development, announced today the expansion of ... has been granted supercomputing time at Argonne National ... Through a discretionary allocation of ... Facility (ALCF), researchers at Cloud Pharmaceuticals will use ...
(Date:7/14/2014)... 2014 Throughout this past June ... clinical trials space, representing 38 countries globally, registered ... “Optimizing Patient Participation in Clinical Trials. Attract. Engage. ... internationally renowned R&D expert, Ken Getz, of Tufts ... Drug Development through Patient Centricity. , Throughout this ...
(Date:7/14/2014)... , July 14, 2014 Minerva Neurosciences (NASDAQ: ... of new therapies to treat neuropsychiatric diseases and disorders, ... been appointed vice president of finance and chief accounting ... is a senior executive with more than 20 years ... and life science companies. His background includes the management ...
(Date:7/14/2014)... 14, 2014 PatientCrossroads, pioneer ... announced that three PatientCrossroads-based patient registries—DuchenneConnect, for ... Syndrome International Registry; and the NephCure Kidney ... contracts by the Patient-Centered Outcomes Research Institute ... a new health data network called PCORnet: ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... , Most Basic Recommended Cecil Instrumentation: , ... 500 l loop , Fraction collector , Column ... : , Researchers need to understand ... protein expression in healthy and diseased cells. , Hence the ...
... reliable and accurate long-range PCR and RT-PCR , ... RT-PCR Kits provide dedicated and highly reliable solutions for long-range,amplification from genomic DNA and cDNA. ... , QIAGEN LongRange PCR ... Amplification of extremely long PCR products up to 40 kb DNA or,12.5 kb ...
... LOS ANGELES, CA (August 10, 2006) - DoveBid, Inc., ( http://www.dovebid.com ... auction and valuation services, announced , today it ... Exchange auction online, on August 15, 2006. The event marks a milestone ... practice, and is expected , to bring to-date ...
Cached Biology Technology:Semi Preparative Purification of Proteins 2QIAGEN LongRange PCR and 2Step RT-PCR Kits 2World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition 2World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition 3
(Date:7/14/2014)... 2014 How does oxygen control insect body size? What ... in the first issue of Current Opinion in Insect ... and more questions. , Current Opinion in Insect Science ... series. It is a review journal that aims to provide ... expanding volume of information published in the field of insect ...
(Date:7/14/2014)... The Biogerontology Research Foundation (BGRF), a UK-based charity ... challenges of a rapidly ageing population, hosted the ... 30th, with Aging Analytics, a company supporting financial ... , The speakers at the forum included: , ... Kong on ,Impact Investment to Advance Longevity Research, ...
(Date:7/14/2014)... discovery and description of Rhipidocyrtus muiri - a ... to represent a new genus and species. The long and ... is discussed in a recent paper published in the open ... male, and only known specimen of Rhipidocyrtus muiri , ... this it was transferred among several researchers in the early ...
Breaking Biology News(10 mins):BGRF hosts inaugural 21st Century Medicine Forum 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3
... the National Institutes of Health will explore the role ... by NIH,s National Institute of Environmental Health Sciences (NIEHS), ... people more vulnerable to heat exposure; changing weather patterns; ... toxic chemicals; and the negative effects of climate change ...
... discovered in the 16-23 million years old sediments of the ... Helophorus sibiricus , a member of the water scavenger ... in Eurasia and reaches even North America. The species was ... based on specimens collected at Lake Baikal. It is aquatic ...
... 2011. In the central Arctic the proportion of old, thick ... largely consists of thin, one-year-old floes. This is one of ... Polar and Marine Research in the Helmholtz Association brought back ... The ship arrived at its home port of Bremerhaven ...
Cached Biology News:NIH launches research program to explore health effects from climate change 2NIH launches research program to explore health effects from climate change 3A living species of aquatic beetle found in 20-million-year-old sediments 2Young and thin instead of old and bulky 2Young and thin instead of old and bulky 3Young and thin instead of old and bulky 4
Immunogen: C terminus [VQLKRSKNDSKPYC] of cardiac elav-type RNA-binding protein (ETR-3) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks...
...
Luminometers...
Biology Products: